4.7 Article

Clinical-Radiological Mismatch in Multiple Sclerosis Patients during Acute Relapse: Discrepancy between Clinical Symptoms and Active, Topographically Fitting MRI Lesions

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI

Assunta Dal-Bianco et al.

Summary: Iron rim lesions in multiple sclerosis patients signify a more severe disease course and propensity to develop progressive disease. Long-term follow-up reveals different dynamics of iron rim lesions in relapsing-remitting versus progressive disease, with potential implications for disease progression and brain damage.
Article Clinical Neurology

A model for interrogating the clinico-radiological paradox in multiple sclerosis: Internuclear ophthalmoplegia

Jenny A. Nij Bijvank et al.

Summary: This study explores the clinico-radiological paradox in multiple sclerosis (MS) using internuclear ophthalmoplegia (INO) and the medial longitudinal fasciculus (MLF) as a model. The presence of INO was found to be related to visual function overall score, while MLF lesions seen on MRI were not. The study provides an objective and quantitative model to investigate the clinico-radiological paradox and suggests that infrared oculography may be more clinically relevant in detecting MLF pathology than MRI.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Clinical Neurology

MRI topography of lesions related to internuclear ophthalmoplegia in patients with multiple sclerosis or ischemic stroke

Marie T. Kleinsorge et al.

Summary: This study retrospectively analyzed MRI examinations of 82 patients, including 40 with multiple sclerosis and 42 with ischemic stroke. The results show that MS patients had more lesions in multiple locations, while stroke patients had more lesions at the level of the mesencephalon.

JOURNAL OF NEUROIMAGING (2021)

Review Immunology

Immunosenescence in multiple sclerosis: the identification of new therapeutic targets

Maria Dema et al.

Summary: The number of elderly multiple sclerosis patients is increasing due to improved life expectancy and available treatments. Current treatments cannot halt disability accumulation associated with disease progression, potentially due to the impact of immunosenescence, leading to abnormal immune cell subsets contributing to autoimmune disease development. Strategies including senolytics, regenerative therapies, and rejuvenation of immune cells have been proposed to potentially reverse immunosenescence and benefit MS progression.

AUTOIMMUNITY REVIEWS (2021)

Article Clinical Neurology

2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

Mike P. Wattjes et al.

Summary: The 2021 revision of guidelines on MRI use for multiple sclerosis patients integrates recommendations from various organizations to improve the application of MRI for diagnosis, prognosis, and monitoring of individuals with multiple sclerosis. It suggests changes in MRI acquisition protocols, cautious use of gadolinium-based contrast agents, and extends recommendations to the use of MRI in children, during pregnancy, and in the post-partum period for patients with multiple sclerosis.

LANCET NEUROLOGY (2021)

Article Clinical Neurology

Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis

Luca Prosperini et al.

Summary: This study found that about one in four relapsing-remitting multiple sclerosis patients achieved NEDA-3 status in the first 2 years but experienced disability accrual in the following years. Different risk factors were associated with relapse-associated worsening and progression independent from relapse activity, suggesting alternative mechanisms for disability accrual.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Review Medicine, General & Internal

Paroxysmal Symptoms in Multiple Sclerosis-A Review of the Literature

Joumana Freiha et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Medicine, General & Internal

Iron Rims as an Imaging Biomarker in MS: A Systematic Mapping Review

Amjad I. AlTokhis et al.

DIAGNOSTICS (2020)

Article Immunology

Mast cell inflammasome activity in the meninges regulates EAE disease severity

Abigail E. Russi et al.

CLINICAL IMMUNOLOGY (2018)

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Review Clinical Neurology

Functional Connectivity in Multiple Sclerosis: Recent Findings and Future Directions

Marlene Tahedl et al.

FRONTIERS IN NEUROLOGY (2018)

Article Medicine, General & Internal

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

S. L. Hauser et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Clinical Neurology

Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse

Elizabeth A. Mills et al.

FRONTIERS IN NEUROLOGY (2017)

Article Clinical Neurology

The relevance of cortical lesions in patients with multiple sclerosis

Olivia Geisseler et al.

BMC NEUROLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Gadolinium tissue deposition in brain and bone

Nozomu Murata et al.

MAGNETIC RESONANCE IMAGING (2016)

Article Multidisciplinary Sciences

A multi-modal parcellation of human cerebral cortex

Matthew F. Glasser et al.

NATURE (2016)

Review Clinical Neurology

Association between pathological and MRI findings in multiple sclerosis

Massimo Filippi et al.

LANCET NEUROLOGY (2012)

Article Medicine, General & Internal

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Robert J. Fox et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Clinical Neurology

Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria

Chris H. Polman et al.

ANNALS OF NEUROLOGY (2011)

Article Medicine, General & Internal

Inflammatory Cortical Demyelination in Early Multiple Sclerosis

Claudia F. Lucchinetti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

Paul O'Connor et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Physiology

Thermoregulation in multiple sclerosis

Scott L. Davis et al.

JOURNAL OF APPLIED PHYSIOLOGY (2010)

Article Medicine, General & Internal

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

Jeffrey A. Cohen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Clinical Neurology

Is multiple sclerosis a generalized disease of the central nervous system? An MRI perspective

Declan Chard et al.

CURRENT OPINION IN NEUROLOGY (2009)

Article Clinical Neurology

The natural history of relapses in multiple sclerosis

Timothy Vollmer

JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)

Article Medicine, General & Internal

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

CH Polman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)